Alkem Laboratories completes sale of unit in US for consideration of $7.96 million

01 Jan 2024 Evaluate

Alkem Laboratories has completed sale of one of its units in the United States (US) for a consideration of $7.96 million. The operations of the company carried out at the St. Louis manufacturing facility situated in USA owned by M/s S&B Pharma LLC, a step-down subsidiary of the company, (Facility) are closed.

Accordingly, all rights, title and interest in the land, improvements and personal property with respect to the said Facility owned by M/s S&B Pharma LLC, a step-down subsidiary of the company in USA (Seller) are sold to M/s New Mill Capital Holdings LLC (Buyer) pursuant to the ‘Purchase and Sale Agreement’ executed between the Buyer and Seller.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5431.85 -65.55 (-1.19%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.